When global trade buckles, Ryan Petersen is the person executives call. The founder and CEO of Flexport returns to Rapid Response to offer a real-time account of the Strait of Hormuz crisis — what he's seeing on the ground, on the water, and across the supply chains straining under the pressure. Petersen also digs into the prospect of tariff refunds in the wake of the Supreme Court's ruling against the Trump Administration, and why businesses risk leaving $160 billion on the table by not acting. Plus, how AI is reshaping both logistics and software-based firms, and whether all the trade turbulence might actually be a tailwind for Flexport itself.

Visit the Rapid Response website here: https://www.rapidresponseshow.com/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

William Shockley was a brilliant inventor and Nobel Prize winner, but he was a terrible boss. Paranoid, cruel, and obsessed with micromanaging, he drove away the team of young engineers — later called “The Traitorous Eight” — he had assembled in Northern California. They went on to pioneer silicon chips, create companies like Intel and AMD, and fund tech giants like Google and Slack. This episode from Business History, hosted by former Planet Money hosts Jacob Goldstein and Robert Smith, tells the story of how one bad boss accidentally sparked the tech revolution that became Silicon Valley.

Find Business History on YouTube, Apple, Spotify, or wherever you get your podcasts: https://lnk.to/BHRapid

Visit the Rapid Response website here: https://www.rapidresponseshow.com/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of Rapid Response, Ro CEO Zach Reitano joins the show to talk about what happens when a breakout drug becomes a full-blown market force. Since first appearing at the height of the Ozempic-Wegovy-Zepbound boom, Reitano has helped scale Ro into a leading provider of branded GLP-1s — grabbing headlines with a Super Bowl ad featuring Serena Williams and landing a major partnership with Novo Nordisk for the new pill version of Wegovy. He also takes on the tougher questions: the long-term health unknowns, the cultural backlash to “Ozempic face,” and what this wave of disruption could mean not just for pharma, but for the future of healthcare.

Visit the Rapid Response website here: https://www.rapidresponseshow.com/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.